Search filters

List of works by Sharon Nachman

A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children

article

A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children

scientific article published on 25 August 2020

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children

scientific article published on October 2010

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy

scientific article published on 14 August 2013

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy

scientific article

Assessing Psychiatric Symptoms in Youth Affected by HIV: Comparing a Brief Self-Administered Rating Scale with a Structured Diagnostic Interview

scientific article published on 19 February 2018

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).

scientific article published on 6 February 2007

COVID-19 pharmacologic treatments for children: research priorities and approach to pediatric studies

scientific article published on 29 June 2020

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.

scientific article published in October 2007

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy

scientific article

Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C Study

scientific article published on 26 October 2012

Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth

scientific article

Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample

scientific article

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

article

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.

scientific article published on 24 October 2017

Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir

scientific article published on 10 September 2016

Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine

scientific article

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study

scientific article

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants

scientific article

Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403.

scientific article

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.

scientific article

Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medi

scientific article published on 27 November 2013

Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children

scientific article published on December 2013

Family Contextual Factors are Differentially Associated with Depressive Symptoms among Boys and Girls with Perinatally Acquired HIV

scientific article published on 08 July 2020

Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors

scientific article

Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy

scientific article published on May 2002

Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

scientific article

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the

scientific article

H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir

scientific article published on 13 February 2017

Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women

scientific article

High Incidence of Tuberculosis Infection in HIV-Exposed Children Exiting an Isoniazid Preventive Therapy Trial.

scientific article

High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088) ⬇️

scientific article published on January 31, 2013

Human Immunodeficiency Virus Disease Severity, Psychiatric Symptoms, and Functional Outcomes in Perinatally Infected Youth ⬇️

scientific article published on June 1, 2012

Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus ⬇️

scientific article published on May 22, 2012

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

scientific article

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.

scientific article

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy

scientific article

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

scientific article published in October 2006

Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children

scientific article published on 27 June 2000

Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection

scientific article published on 29 June 2005

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

scientific article published on February 2009

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

scientific article published on July 2006

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities

scientific article published on 12 July 2019

Longitudinal Study of Emerging Mental Health Concerns in Youth Perinatally Infected With HIV and Peer Comparisons ⬇️

scientific article published on July 1, 2012

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

scientific article published in July 2004

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

scientific article published on 10 July 2019

Mental health treatment patterns in perinatally HIV-infected youth and controls

scientific article published on 13 July 2009

Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161)

article

Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure

scientific article

Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1.

scientific article published in April 2002

Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377.

scientific article published on September 2003

Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.

scientific article published in February 2005

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team

scientific article published in The Journal of the American Medical Association

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

scientific article published on 27 February 2002

Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 psychiatric comorbidity study

scientific article published on July 2013

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

scientific article published on 15 October 2007

Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection

scientific article published on April 2004

Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age

scientific article

Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents

scientific article published in September 2010

Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years

scientific article published on 21 October 2013

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents

scientific article

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age

scientific article

Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households

scientific article

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children

scientific article

Profiles of caregiving behaviors among children and adolescents with perinatally acquired HIV

scientific article published on 07 February 2019

Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection

journal article published in 2004

Psychiatric symptoms and antiretroviral nonadherence in US youth with perinatal HIV: a longitudinal study

scientific article published in June 2015

Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children

scholarly article by Elin M Svensson et al published 27 June 2018 in British Journal of Clinical Pharmacology

Reply to Holm et al

scientific article published on 13 December 2012

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection

scientific article

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy

scientific article published in August 2006

Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1-Infected Children, Adolescents, and Young Adults ⬇️

scientific article published on May 21, 2012

Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial

scientific article

Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women

scientific article

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

scientific article published in July 2003

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children

scientific article published on January 2012

Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer ⬇️

scientific article published on April 13, 2011

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children

scientific article published on 10 June 2008

Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.

scientific article

Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection

scientific article published in February 2002

Substance use and its association with psychiatric symptoms in perinatally HIV-infected and HIV-affected adolescents

scientific article

Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children

scientific article published on 2 March 2005

T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines

scientific article

Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection

scientific article published on 01 September 2005

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

scientific article

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

scientific article published on 16 March 2005

Towards early inclusion of children in tuberculosis drugs trials: a consensus statement

scientific article published on 6 May 2015

Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment

scientific article

Paulina is supported by:

About Paulina

Help